Through a combination of in vivo and in vitro analyses, we delineated a mechanistic axis wherein NETs promote cardiac fibrosis via induction of oxidative stress, ferroptotic cell death, and pro-fibrotic gene expression—processes that are significantly mitigated by pharmacological inhibition of either ferroptosis or NF-κB. Here, NFKB1 is linked to fibrosis.